CT
LLY icon

Columbia Trust’s Eli Lilly LLY Stock Holding History

Columbia Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$616K Buy
1,056
+39
+4% +$22.8K 0.28% 87
2023
Q3 		$546K Buy
1,017
+4
+0.4% +$2.06K 0.32% 81
2023
Q2 		$475K Sell
1,013
-25
-2% -$10.5K 0.27% 87
2023
Q1 		$356K Buy
1,038
+7
+0.7% +$2.36K 0.21% 108
2022
Q4 		$377K Sell
1,031
-55
-5% -$19.5K 0.21% 105
2022
Q3 		$351K Hold
1,086
– – 0.2% 101
2022
Q2 		$352K Sell
1,086
-220
-17% -$66K 0.19% 105
2022
Q1 		$394K Sell
1,306
-28
-2% -$7.21K 0.18% 109
2021
Q4 		$308K Hold
1,334
– – 0.16% 113
2021
Q3 		$308K Buy
1,334
+150
+13% +$37K 0.16% 113
2021
Q2 		$272K Buy
+1,184
New +$238K 0.16% 121
2020
Q2 		$246K Sell
1,503
-906
-38% -$139K 0.22% 108
2020
Q1 		$333K Buy
2,409
+18
+0.8% +$2.47K 0.36% 81
2019
Q4 		$314K Buy
+2,391
New +$277K 0.28% 102

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Columbia Trust's LLY Position: Q4 2023 in Review

Columbia Trust increased its Eli Lilly (LLY) stake by 3.8% in Q4 2023, buying an estimated $22.8K and bringing the position to 1,056 shares worth $616K. The position accounts for 0.28% of the portfolio, ranked #87.

Columbia Trust first reported a position in LLY in Q4 2019 and has held it in 14 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Columbia Trust held 1,056 shares of Eli Lilly worth $616K as of Q4 2023.
  • Columbia Trust bought 39 Eli Lilly shares in Q4 2023, an estimated $22.8K.
  • Eli Lilly made up 0.28% of Columbia Trust's portfolio in Q4 2023, its #87 holding.
  • Columbia Trust first reported a position in Eli Lilly in Q4 2019 and has held it in 14 quarters since.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.